Czech; Jorg

Patent Applications and Registrations

Patent applications and USPTO patent grants for Czech; Jorg.The latest application filed is for "fusion proteins for prodrug activation".

Company Profile

0.13.3

Czech; Jorg - Marburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fusion proteins for prodrug activation Grant 7,273,727 - Gehrmann , et al. September 25, 2	2007-09-25
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates Grant 7,241,595 - Kolar , et al. July 10, 2	2007-07-10
Fusion proteins for prodrug activation App 20060292139 - Gehrmann; Mathias ; et al.	2006-12-28
Fusion proteins for prodrug activation Grant 7,060,495 - Gehrmann , et al. June 13, 2	2006-06-13
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates Grant 6,610,299 - Kolar , et al. August 26, 2	2003-08-26
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates App 20030064482 - Kolar, Cenek ; et al.	2003-04-03
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates Grant 6,475,486 - Kolar , et al. November 5, 2	2002-11-05
Fusion Proteins For Prodrug Activation App 20020068329 - GEHRMANN, MATHIAS ; et al.	2002-06-06
Prodrugs, their preparation and use as pharmaceuticals Grant 6,146,658 - Bosslet , et al. November 14, 2	2000-11-14
Preparation having increased in vivo tolerability Grant 6,020,315 - Bosslet , et al. February 1, 2	2000-02-01
Prodrugs their preparation and use as pharmaceuticals Grant 5,955,100 - Bosslet , et al. September 21, 1	1999-09-21
Prodrugs for the therapy of tumors and inflammatory disorders Grant 5,935,995 - Bosslet , et al. August 10, 1	1999-08-10
Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders Grant 5,886,033 - Schwab , et al. March 23, 1	1999-03-23
Pro-prodrugs, their production and use Grant 5,877,158 - Bosslet , et al. March 2, 1	1999-03-02
Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders Grant 5,710,134 - Bosslet , et al. January 20, 1	1998-01-20
Use of derivatives of 9,10-dihydrophenanthrene for the preparation of an anti-tumor medicament Grant 5,189,065 - Czech , et al. February 23, 1	1993-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.